These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 17101102)
1. [Coagulation factor mutations and thrombosis]. Aiach M; Alhenc-Gelas M; Borgel D; Emmerich J; Gandrille S; Picard V Med Sci (Paris); 2006 Nov; 22(11):985-9. PubMed ID: 17101102 [TBL] [Abstract][Full Text] [Related]
2. Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management. Dahlbäck B Semin Hematol; 1997 Jul; 34(3):217-34. PubMed ID: 9241707 [TBL] [Abstract][Full Text] [Related]
3. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia. Ruggeri M; Gisslinger H; Tosetto A; Rintelen C; Mannhalter C; Pabinger I; Heis N; Castaman G; Missiaglia E; Lechner K; Rodeghiero F Am J Hematol; 2002 Sep; 71(1):1-6. PubMed ID: 12221665 [TBL] [Abstract][Full Text] [Related]
4. Thrombin generation as an intermediate phenotype for venous thrombosis. Segers O; van Oerle Rv; ten Cate Ht; Rosing J; Castoldi E Thromb Haemost; 2010 Jan; 103(1):114-22. PubMed ID: 20062924 [TBL] [Abstract][Full Text] [Related]
5. [Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis]. Miljić P; Rolović Z; Elezović I; Antunović P; Stanojević M; Colović M Srp Arh Celok Lek; 1999; 127(1-2):21-7. PubMed ID: 10377836 [TBL] [Abstract][Full Text] [Related]
6. Risk of thrombosis associated with oral contraceptives of women from 97 families with inherited thrombophilia: high risk of thrombosis in carriers of the G20210A mutation of the prothrombin gene. Santamaría A; Mateo J; Oliver A; Menéndez B; Souto JC; Borrell M; Soria JM; Tirado I; Fontcuberta J Haematologica; 2001 Sep; 86(9):965-71. PubMed ID: 11532625 [TBL] [Abstract][Full Text] [Related]
7. Screening for inherited thrombophilia: indications and therapeutic implications. De Stefano V; Rossi E; Paciaroni K; Leone G Haematologica; 2002 Oct; 87(10):1095-108. PubMed ID: 12368166 [TBL] [Abstract][Full Text] [Related]
8. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis. Dahlbck B J Intern Med Suppl; 1997; 740():1-8. PubMed ID: 9350175 [TBL] [Abstract][Full Text] [Related]
9. Inherited thrombophilia, pregnancy, and oral contraceptive use: clinical implications. De Stefano V; Rossi E; Leone G Semin Vasc Med; 2003 Feb; 3(1):47-60. PubMed ID: 15199492 [TBL] [Abstract][Full Text] [Related]
10. Activated protein C resistance and thrombosis: molecular mechanisms of hypercoagulable state due to FVR506Q mutation. Dahlbäck B Semin Thromb Hemost; 1999; 25(3):273-89. PubMed ID: 10443959 [TBL] [Abstract][Full Text] [Related]
11. Laboratory assessment of hypercoagulable state. A study in a group of patients with venous thromboembolism born in Chioggia. Gessoni G; Valverde S; Canistro R; Trabuio E; Antico F; Manoni F Minerva Med; 2007 Apr; 98(2):89-93. PubMed ID: 17519850 [TBL] [Abstract][Full Text] [Related]
12. [Pregnancy-associated venous thrombosis in women with hereditary heterozygous factor V Leiden and/or factor II gene mutations]. Samama MM; Rached RA; Conard J; Horellou MH; Elalamy I Bull Acad Natl Med; 2004; 188(8):1377-93; discussion 1393-6. PubMed ID: 15918665 [TBL] [Abstract][Full Text] [Related]
13. Genetic screening of candidate genes for a prothrombotic interaction with type I protein C deficiency in a large kindred. Scott BT; Bovill EG; Callas PW; Hasstedt SJ; Leppert MF; Valliere JE; Varvil TS; Long GL Thromb Haemost; 2001 Jan; 85(1):82-7. PubMed ID: 11204593 [TBL] [Abstract][Full Text] [Related]
15. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients. Jespersen J Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796 [TBL] [Abstract][Full Text] [Related]
16. Contribution of prothrombin 20210A allele and factor V Leiden mutation to thrombosis risk in thrombophilic families with other hemostatic deficiencies. Tirado I; Mateo J; Soria JM; Oliver A; Borrell M; Coll I; Vallvé C; Souto JC; Martínez-Sánchez E; Fontcuberta J Haematologica; 2001 Nov; 86(11):1200-8. PubMed ID: 11694407 [TBL] [Abstract][Full Text] [Related]
17. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism. Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312 [TBL] [Abstract][Full Text] [Related]
18. [Changes in hemostasis system in patients with hereditary thrombophilia caused by mutation of blood coagulation factor V ( factor V Leiden)]. Papaian LP; Kobilianskaia VA; Sheĭdina AM; Baranovskaia SS; Sirotkina OV; Kargin VD; Saltykova NB; Beliazo OE; Golovina OG; Papaian KA; Tarkovskaia LR Ter Arkh; 2001; 73(7):47-51. PubMed ID: 11523408 [TBL] [Abstract][Full Text] [Related]
19. Role of the geneticist in testing and counseling for inherited thrombophilia. Reich LM; Bower M; Key NS Genet Med; 2003; 5(3):133-43. PubMed ID: 12792420 [TBL] [Abstract][Full Text] [Related]
20. Comparison of thrombophilic gene mutations among patients experiencing recurrent miscarriage and deep vein thrombosis. Coulam CB; Wallis D; Weinstein J; DasGupta DS; Jeyendran RS Am J Reprod Immunol; 2008 Nov; 60(5):426-31. PubMed ID: 18803625 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]